Royce & Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-300,619	Closed	-$394K	–	790
2025 Q3	$394K	Sell	300,619 -205,441	-41%	-$213K	﹤0.01%	721
2025 Q2	$363K	Sell	506,060 -229,376	-31%	-$180K	﹤0.01%	738
2025 Q1	$1.08M	Hold	735,436	–	–	0.01%	664
2024 Q4	$3.26M	Buy	735,436 +72,502	+11%	+$294K	0.03%	553
2024 Q3	$2.73M	Buy	662,934 +64,353	+11%	+$346K	0.02%	580
2024 Q2	$3.9M	Buy	598,581 +7,577	+1%	+$53.6K	0.04%	526
2024 Q1	$5.15M	Buy	591,004 +292,241	+98%	+$3.55M	0.05%	488
2023 Q4	$3.42M	Buy	298,763 +14,013	+5%	+$139K	0.03%	568
2023 Q3	$2.74M	Buy	284,750 +2,130	+0.8%	+$20.9K	0.03%	604
2023 Q2	$3.01M	Sell	282,620 -1,603,627	-85%	-$17.2M	0.03%	601
2023 Q1	$19.8M	Buy	1,886,247 +210,758	+13%	+$2.36M	0.2%	136
2022 Q4	$20.8M	Sell	1,675,489 -2,722	-0.2%	-$30.9K	0.22%	119
2022 Q3	$17.4M	Buy	1,678,211 +184,574	+12%	+$2.09M	0.2%	134
2022 Q2	$17.2M	Buy	1,493,637 +332,791	+29%	+$3.92M	0.18%	151
2022 Q1	$14.6M	Buy	1,160,846 +679,997	+141%	+$7.8M	0.12%	241
2021 Q4	$5.61M	Buy	+480,849	New	+$5.9M	0.04%	539
2020 Q3	–	Sell	-2,328	Closed	-$24K	–	1078
2020 Q2	$24K	Buy	2,328 +463	+25%	+$4.74K	﹤0.01%	1108
2020 Q1	$19K	Buy	+1,865	New	+$21.9K	﹤0.01%	1092